Kang Sok-Leng, Jaeggi Edgar, Ryan Greg, Chaturvedi Rajiv R
Division of Cardiology, Labatt Heart Centre, The Hospital for Sick Children, Toronto, ON, M5G 1X8, Canada.
Fetal Medicine Unit, Department of Obstetrics and Gynecology, Mt Sinai Hospital, Toronto, ON, M5G 1X5, Canada.
Pediatr Cardiol. 2020 Mar;41(3):479-485. doi: 10.1007/s00246-020-02294-2. Epub 2020 Mar 20.
Fetal cardiac interventions (FCI) offer the opportunity to rescue a fetus at risk of intrauterine death, or more ambitiously to alter disease progression. Most of these fetuses require multiple additional postnatal procedures, and it is difficult to disentangle the effect of the fetal procedure from that of the postnatal management sequence. The true clinical impact of FCI may only be discernible in large-volume institutions that can commit to a standardized postnatal approach and have sufficient case volume to overcome their FCI learning curve.
胎儿心脏介入治疗(FCI)为挽救有宫内死亡风险的胎儿提供了机会,或者更有雄心地改变疾病进展。这些胎儿中的大多数需要多次额外的出生后治疗,并且很难区分胎儿治疗与出生后管理序列的效果。FCI的真正临床影响可能只有在能够采用标准化出生后治疗方法并拥有足够病例数量以克服FCI学习曲线的大型机构中才能显现出来。